You just read:

Thermo Fisher Scientific Signs Development Agreement with Agios Pharmaceuticals for Next-Generation Sequencing Oncology Companion Diagnostic in Cholangiocarcinoma

News provided by

Thermo Fisher Scientific Inc.

May 18, 2017, 08:00 ET